各项收入占比是对three months ended June 30, 2026的估算,并非来自已提交报告的数字。
Routine and non-routine clinical laboratory tests
Tests of blood, urine and other samples, including common checks of blood counts, organ function, allergies and infections, as well as more specialized tests.
Advanced diagnostic tests
Specialized tests in areas such as cancer, genetics, brain health and autoimmune disease. Examples include blood tests for Alzheimer’s disease risk and Haystack testing for signs of remaining or returning cancer.
Anatomic pathology
Examination of tissue and cell samples to help diagnose cancer and other diseases.
Collaborative Lab Solutions
Services that help hospitals manage their laboratories, choose tests, control supply costs and use laboratory data.
QuestHealth.com
A website where people can buy health and wellness tests, with physician review of test orders and the option to discuss results with a physician.
ExamOne
Examinations, sample testing and information gathering that help life insurers assess insurance applicants.
Quest Diagnostics collects and tests blood, urine, tissue and other samples, then provides results that help healthcare professionals diagnose, monitor and treat medical conditions. It also performs tests that hospitals send to outside laboratories, helps hospitals run their own labs, and offers testing and data services to insurers and other organizations. It processed 244 million test requisitions (2025, high).
基于 Quest Diagnostics Inc. 自己向美国证券交易委员会(SEC)提交的申报文件。数字如实呈报,每股历史已重述到今天的股数口径。 这是对一门生意的描述——不是投资建议,也不是买卖任何证券的推荐。
The themes Quest Diagnostics is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
US$259.690.0%11月13日 收盘
数据截至2026年9月30日,来自2026年10月23日提交的10-Q
Quest Diagnostics performs medical tests on blood and other samples for doctors, hospitals, health plans and patients.
公司指引:2026 财年营收 US$12.1B 至 US$12.1B — 同比增长 9.5%
Grade A
价格下方的色带显示每个日期的评级,仅依据当时已公开的文件计算。
显示 Quest Diagnostics Inc. 评级历史 40 个季度中的 2 个。 其余 38 个可回溯到 2017年2月。